Inhibitors of hepatitis C virus RNA-dependent RNA polymerase
AssigneeAgouron Pharmaceuticals, Inc.
InventorsAllen J. Borchardt, Peter Scott Dragovich, Javier Gonzalez, Tanya Michelle Jewell, Hui Li, Maria Angelica Linton, John Howard Tatlock, Ru Zhou, Thomas Jay Prins, Melwyn A. Abreo
Life of this patent
Estimating the term…
Abstract
Compounds of formula I are hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp) inhibitors, and are useful in therapeutic and prophylactic treatment of persons infected with hepatitis C virus
Claims2
A method of inhibiting HCV polymerase activity, comprising contacting an HCV polymerase with an effective amount of a compound selected from the group consisting of:
A method of inhibiting HCV polymerase activity, comprising contacting an HCV polymerase with an effective amount of a compound selected from the group consisting of:
Dependencies are inferred from the claim text.